// Workers AI · dad joke modeDoes ethinylestradiol/desogestrel have a relationship? Yes, it's a pill-ar bond.

Desogestrel/ethinylestradiol
	Ethinylestradiol
	Desogestrel
Combination of
Ethinylestradiol	Estrogen
Desogestrel	Progestogen (Progestin)
Clinical data
Trade names	Marvelon, Desogen, Ortho-cept, others
Other names	EE/DSG, EE-DSG, DSG+EE
AHFS/Drugs.com	Professional Drug Facts
MedlinePlus	a601050
Routes of; administration	By mouth
ATC code	G03AA09 (WHO) ;
Legal status
Legal status	CA: ℞-only; UK: POM (Prescription only); US: ℞-only; EU: Rx-only;
Identifiers
CAS Number	71138-35-7;

Ethinylestradiol/desogestrel (EE/DSG), sold under the brand name Marvelon among others, is a fixed-dose combination of ethinylestradiol (EE), an estrogen, and desogestrel (DSG), a progestin, which is used as a birth control pill to prevent pregnancy in women.^[2]^[3]^[5]^[6] It is taken by mouth.^[3]

It was approved for medical use in the United Kingdom in 1981,^[2] and in the United States in 1992.^[3] In 2023, it was the 225th most commonly prescribed medication in the United States, with more than 1 million prescriptions.^[7]^[8]

References

↑ "Product monograph brand safety updates". Health Canada. 7 July 2016. Retrieved 3 April 2024.
1 2 3 "Marvelon Tablets - Summary of Product Characteristics (SmPC)". (emc). 11 March 2021. Retrieved 18 June 2021.
1 2 3 4 "Desogen Tablets (desogestrel and ethinyl estradiol tablets USP)". DailyMed. 18 June 2018. Retrieved 18 June 2021.
↑ "List of nationally authorised medicinal products" (PDF). European Medicines Agency.
↑ Pundir J, Coomarasamy A (21 April 2016). Gynaecology: Evidence-Based Algorithms. Cambridge University Press. pp. 260–. ISBN 978-1-316-30110-4.
↑ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 435, 436, 455, 459. ISBN 978-92-832-1291-1.
↑ "The Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.
↑ "Desogestrel; Ethinyl Estradiol Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 20 August 2025.

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by adding missing information.

[1] "Product monograph brand safety updates". Health Canada. 7 July 2016. Retrieved 3 April 2024.

[Marvelon_SmPC-2] 1 2 3 "Marvelon Tablets - Summary of Product Characteristics (SmPC)". (emc). 11 March 2021. Retrieved 18 June 2021.

[Desogen_FDA_label-3] 1 2 3 4 "Desogen Tablets (desogestrel and ethinyl estradiol tablets USP)". DailyMed. 18 June 2018. Retrieved 18 June 2021.

[4] "List of nationally authorised medicinal products" (PDF). European Medicines Agency.

[PundirCoomarasamy2016-5] Pundir J, Coomarasamy A (21 April 2016). Gynaecology: Evidence-Based Algorithms. Cambridge University Press. pp. 260–. ISBN 978-1-316-30110-4.

[HumansOrganization2007-6] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 435, 436, 455, 459. ISBN 978-92-832-1291-1.

[7] "The Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.

[8] "Desogestrel; Ethinyl Estradiol Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 20 August 2025.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

This page was redesigned at the edge.

A page that knows where it met you.

// Workers AI · dad joke modeDoes ethinylestradiol/desogestrel have a relationship? Yes, it's a pill-ar bond.

See also

References